Prostaglandin E1 treatment of congenital heart disease with pulmonary hypertension Effect.doc
- 1、本文档共7页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Prostaglandin E1 treatment of congenital heart disease with pulmonary hypertension Effect
PAGE \* MERGEFORMAT 7
Prostaglandin E1 treatment of congenital heart disease with pulmonary hypertension Effect
Author: Kung-bin, Zhang Zhiyong, Su scientist, Su Xia
Keywords:: Congenital heart disease; pulmonary hypertension; prostaglandin E1
[Abstract] Objective To observe the prostaglandin E1 on pulmonary hypertension in congenital heart disease with the hemodynamic effects. Methods 60 patients with congenital heart disease with pulmonary hypertension were randomly divided into treatment group and control group, control group, 30 cases of conventional therapy, the treatment group 30 cases on the basis of conventional therapy with prostaglandin E1 treatment. Results of clinical symptoms, mean pulmonary artery pressure mPAP, arterial partial pressure of oxygen, arterial oxygen saturation has improved significantly. Conclusion PGE1 can significantly improve the clinical symptoms, a significant reduction in mPAP, to improve arterial oxygen and arterial oxygen saturation, pulmonary hypertension with congenital heart disease treatment effective.
[Keywords:] congenital heart disease; pulmonary hypertension; prostaglandin E1
A study of PGE1 in treatment of pulmonary hypertension associated with congenital heart defect
[Abstract] Objective To evaluate the effect of prostaglandin E1 with congenital heart defects and pulmonary hypertension.Methods 60 patients with congenital heart disease and pulmonary hypertension were randomly divided into therapeutic group and control group (30 case) were traditionally treated and the therapeutic group ( 30 case) were treated with prostaglandin E1 based on the traditional therapy.Results after administration of PGE1, the mean pulmonary artery pressure (mPAP) was significantly reduced, the PaO2 and SaO2 were significantly increased.Conclusion Prostaglandin E1 therapy have effetive on pulmonary hypertension associated with congenital heart defect.
[Keywords:] congenital heart defect; prostaglandin E
您可能关注的文档
- Progress in invasion and metastasis of breast cancer.doc
- Progress in lithium salt Monitoring Methods.doc
- Progress in lipid-lowering medicine research.doc
- Progress in its separate analysis of traditional Chinese medicine.doc
- Progress in Mechanism of trichosanthin.doc
- Progress in medical therapy for esophageal cancer.doc
- Progress in lung cancer stem cell research.doc
- Progress in liver sinusoidal endothelial cells.doc
- Progress in medicine and earthworm.doc
- Progress in medicine and earthworm_0.doc
最近下载
- TBIE 004—2023通孔回流焊接技术规范团标.pdf
- 国开《MySQL数据库应用》形考1-4(试题及答案).pdf VIP
- 煤矿安全生产作业规程操作规程安全技术措施编制审批贯彻及执行管理制度.doc
- 2020年光学膜行业研究报告.pdf
- 采血管种类和应用ppt课件.pptx VIP
- 职业生涯报告六篇.pdf VIP
- Unit 4 Plants arounds us PartA Let's talk(课件)人教PEP版(2024)英语三年级上册.pptx
- 七年级上册生物:必考问答式知识点汇总(背诵+默写).docx
- 《青纱帐——甘蔗林》课件【中职专用】高教版 基础模块下册.pptx
- 国家开放大学学位英语历年真题试卷号1909.docx
文档评论(0)